CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$50.50 +0.62 (+1.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Total Current Liabilities (2015 - 2026)

Updated

CRISPR Therapeutics AG's Total Current Liabilities was $132.9 million in Q2 2026, up 27.3% from $104.36 million a year earlier but down 2.5% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Total Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at CRISPR Therapeutics AG came in at $149.12 million, up 69.9% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $87.78 million in FY2024 (-19.3%), $108.79 million in FY2023 (-10.2%), $121.11 million in FY2022 (+1.0%) and $119.88 million in FY2021 (+27.2%).
  • Quarterly Total Current Liabilities has moved between $87.78 million (Q4 2024) and $150.87 million (Q3 2022) over five years.
  • Compared with a year earlier, Total Current Liabilities has increased for four straight quarters, with growth averaging 10.9% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q4 2025 (growth of 69.9%); the worst was Q3 2023 (a decline of 26.3%).
  • Per Business Quant data, CRSP's Total Current Liabilities in the three quarters before Q2 2026 was $136.29 million (Q1 2026), $149.12 million (Q4 2025) and $118.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 CRISPR Therapeutics AG 4.88 Bn -3.82 Bn - 132.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 132.90 Mn
Mar 31, 2026 136.29 Mn
Dec 31, 2025 149.12 Mn
Sep 30, 2025 118.96 Mn
Jun 30, 2025 104.36 Mn
Mar 31, 2025 119.45 Mn
Dec 31, 2024 87.78 Mn
Sep 30, 2024 89.81 Mn
Jun 30, 2024 127.82 Mn
Mar 31, 2024 118.99 Mn
Dec 31, 2023 108.79 Mn
Sep 30, 2023 111.23 Mn
Jun 30, 2023 132.84 Mn
Mar 31, 2023 146.79 Mn
Dec 31, 2022 121.11 Mn
Sep 30, 2022 150.87 Mn
Jun 30, 2022 119.96 Mn
Mar 31, 2022 113.70 Mn
Dec 31, 2021 119.88 Mn
Sep 30, 2021 96.21 Mn
API Access

CRISPR Therapeutics AG Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CRSP&period=max&api_key=YOUR_API_KEY